Home - Products - Others - Other Targets - Phospholipase A2 Activating Peptide

Phospholipase A2 Activating Peptide

CAS No. 137314-60-4

Phospholipase A2 Activating Peptide( ——— )

Catalog No. M42207 CAS No. 137314-60-4

Phospholipase A2 Activating Peptide

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Phospholipase A2 Activating Peptide
  • Note
    Research use only, not for human use.
  • Brief Description
    Phospholipase A2 Activating Peptide
  • Description
    Phospholipase A2 Activating Peptide
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    137314-60-4
  • Formula Weight
    2330.8
  • Molecular Formula
    C106H184N28O30
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Clobetasone butyrate

    Clobetasone butyrate can be used to relieve corticosteroid-responsive dermatoses, including atopic?dermatitis and psoriasis.

  • Rhamnetin 3-galactos...

    Rhamnetin 3-galactoside is a natural product for research related to life sciences.

  • Syk Inhibitor II hyd...

    The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.